Androgen receptors in ovarian tumors: Correlation with oestrogen and progesterone receptors in an immunohistochemical and semiquantitative image analysis study

Journal of Experimental and Clinical Cancer Research

Volumn 17, Issue 2, 1998, Pages 231-237

  Cardillo, M R ^a,b   Petrangeli, E ^b   Aliotta, N ^a   Salvatori, L ^b   Ravenna, L ^b   Chang, C ^c   Castagna, G ^a  

^a Histopathology Unit   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Androgen receptors; Image analysis; Immunohistochemistry; Ovarian cancer

Indexed keywords

ANDROGEN RECEPTOR; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; CONTROLLED STUDY; DENSITOMETRY; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY TUMOR; PRIORITY JOURNAL; PROGNOSIS;

DENSITOMETRY; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; OVARIAN NEOPLASMS; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 0031839905     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Mooradian A.D., Morley J.E., Korenman S.G.: Biological actions of androgens. Endocr. Rev. 8: 1, 1987.
2. Ino Y., Takizawa R., Sato M. et al.: Localization of sex steroid hormone and sex steroid hormone receptors in human epithelial tumor. Nippon Sanka Fujinka Gakkai Zasshi 42: 9-15, 1990.
3. Ruizeveld De Winter J.A., Trapman J., Vermey M., Mulder E., Zegers N.D., Van der Kwast T.H.: Androgen receptor expression in human tissues: an immuno-histochemical study. J. of Histochemistry and Cytochemistry 39 (7): 927-936, 1991.
4. Nagasue N., Kohno H., Chang Y., Hayashi T., Utsumi Y., Nakamura T., Yukaya H.: Androgen and estrogen receptors in hepatocellular carcinoma and the surrounding liver in women. Cancer 63: 112-116, 1989.
5. Burgess H.E. and Shousha S.: An immunohistochemical study of the long-term effects of androgen administration on female-male transsexual breast: a comparison with normal female breast and male breast showing gynaecomastia. J. of Pathology 170: 37-43, 1993.
6. Isola J.J.: Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors. J Pathol 170: 31-35, 1993.
7. Lai L.C., Ghilchick M.W., Shaikh N.A., Reed M.J., James V.H.T.: Relationship between epidermal growth factor and dehydroepiandrosterone and its sulphate in breast cyst fluid. Br. J. Cancer 60: 320-323, 1989.
8. Hirai M., Hirata S., Osada T., Hagihara K., Kato J.: Androgen receptor mRNA in the rat ovary and uterus. J. Steroid Biochem. Mol. Biol. 49 (1): 1-7, 1994.
9. Ito A., Sato W., Mori Y.: Identification and partial characterization of the cytoplasmic androgen receptor in bovine ovarian capsule. J. Steroid Biochem. 23 (1); 27-37, 1985.
10. Hillier S.G., De Zwart F.A.: Evidence that granulosa cell aromatase induction/activation by follicle-stimulating hormone is an androgen receptor-regulated process in vitro. Endocrinology 109: 1303-1305, 1981.
11. McDonald P.C., Grodin J.M., Edman C.D., Vellios F., Siiteri P.K.: Origin of estrogen in a postmenopausal woman with nonendocrine tumor of the ovary and endometrial hyperplasia. Obst. Gynec. 47: 644-650, 1976.
12. Horie K., Takakura K., Fujiwara H., Suginami H., Liao S., Mori T.: Immunohistochemical localization of androgen receptor in the human ovary throughtout the menstrual cycle in relation to oestrogen and progesterone receptor expression. Human reproduction 7 (2): 184-190, 1992.
13. Hsueh A.J.W.: Paracrine mechanisms involved in granulosa cell differentiation. Clin. Endocrinol. Metab. 15: 117-134, 1986.
14. Richards S.: Maturation of ovarian follicles; action and interaction of pituitary and ovarian hormones on follicular differentiation. Physiol. Rev. 60: 51-89, 1980.
15. Slotman B.J., Rao B.R.: Ovarian cancer (review). Etiology, diagnosis, prognosis, surgery, radiotherapy, chemiotherapy and endocrine therapy. Anticancer Res. 8: 417-434, 1988.
16. Kuhnel R., DE Graaff J., Rao B.R. et al.: Androgen receptor predominance in human ovarian carcinoma. J. Steroid. Biochem. 26: 393-397, 1987.
17. Quinn M.A., Pearce P., Rome R. et al.: Cytoplasmic steroid receptors in ovarian tumours. Br. J. Obst. Gynaecol: 89: 754-759, 1982.
18. Berns E.M.J.J., Kllin J.G.M., Henzen-Logmans S., Rodenburg C.J., Van Der burg M.E.L., Foekens J.A.: Receptors for hormones and growth factors and (onco)-gene amplification in human ovarian cancer. Int. J. Cancer 52: 218-224, 1992.
19. Kieback D.G., McCamant S.K., Press M.E., Atkinson E.N., Gallager H.S., Edward C.L., Hajek R.A., Jones L.A.: Improved prediction of survival in advanced adenocarcinoma of the ovary by immunocytochemical analysis and the composition adjusted receptor level of the estrogen receptor. Cancer Research 53: 5188-5192, 1993.
20. Selveda P., Denison U., Schemper M., Spona J., Vavra N., Salzer H.: Oestrogen and progesterone receptor content as a prognostic factor in advanced epithelial ovarian carcinoma. Br. J. Obstet. Gynaecol. 97: 706-712, 1990.
21. Tani E., Borregon A., Humla S., Skoog L.: Estrogen receptors in fine-needle aspirates from metastatic lesions of gynaecologic tumors. Gynecologic Oncology 32: 365-367, 1989.
22. Slotman B.J., Kunhel R., Rao B.R., Dijkhuizen G.H., De Graaff J., Stolk J.G.: Importance of steroid receptors and aromatase activity in the prognosis of ovarian cancer: high tumor progesterone receptor levels correlate with longer survival. Gynec. Oncol. 33: 76-81, 1989.
23. Slotman B.J., Nauta J.J.P., Rao B.R.: Survival of patients with ovarian cancer: apart from stage and grade, tumor progesterone receptor content is a prognostic indicator. Cancer 66: 740-744, 1990.
24. Noguchi T., Kitawaki J., Tamura T., Kim T., Kanno H., Yamamoto T., Okada H.: Relationship between aromatase activity and steroid receptor level in ovarian tumors from postmenopausal women. J. Steroid. Biochem. Mol. Biol. 44 (4-6): 657-660, 1993.
25. McLusky N.J., Voit R., Lazo J.S., Schwartz P.E., Merino M.J., Eisenfeld A.E., Naftolin F.: Aromatase activity in human cancer. Steroid 50: 423-433, 1987.
26. Thompson M.A., Adelson M.D., Kaufman L.M., Marshall L.D., Coble D.A.: Aromatization of testosterone by epithelial tumor cells cultured from patients with ovarian carcinoma. Cancer Res. 48: 6491-6497, 1988.
27. Trapani A.: I recettori per gli estrogeni (ER) e per il progesterone (PgR) nel cancro ovarico. Minerva Ginecol. 44: 307-312, 1992.
28. Greenbatt R.B., Colle M.L., Mahesh V.B.: Ovarian and adrenal steroid production in the postmenopausal women. Obst. Gynecol. 47: 383-387, 1976.
29. Vermeulen A.: The hormonal activity of postmenopausal ovary. J. Clin. Endocrinol. Metab. 42: 247-253, 1976.
30. Lucisano A., Acampora M.G., Russo N., Maniccia E., Montemurro A., Dell'Acqua S.: Ovarian and peripheral plasma levels of progestogens, androgens and oestrogens in postmenopausal women. Maturitas 6: 45-53, 1984.
31. Schenker J.G., Polishuk W.Z. and Eckstein B.: Pathways in the biosynthesis of androgens in the postmenopausal ovary in vitro. Acta Endocr. Copenh. 66: 325-332, 1971.
32. Airman J., Forney J.P., Parker C.R.: Secretion of androgens and estrogens by normal and neoplastic ovaries in postmenopausal women. Obstet. Gynec. 68: 1-5, 1986.
33. McClelland R.A., Finlay P., Walker K.J., Nicholson D., Robertson JFR., Blamey RW., Nicholson R.I.: Automated quantification of immunocytochemically localized estrogen receptors in human breast cancer. Cancer Res. 50: 3545-3550, 1990.
34. McCarty K.S. Jr., Miller L.S., Cox E.B., Konarth J., McCarty K.S. Sr.: Estrogen receptor analyses: correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch. Pathol. Lab. Med. 109: 716-721, 1985.
35. Goldberg D.E., Stuart J., Koener F.C.: Progesterone receptor detection in paraffin sections of human breast cancers by an immunoperoxidase technique incorporating microwave heating. Mod. Pathol. 7: 401-406, 1994.
36. Chang C., Whelan C.T., Popovich T.C., Kokontis J., Liao S. Fusion protein containing androgen sequences and their use in the production of poly-and monoclonal anti-androgen receptor antibodies. Endocrinology 125: 1097-1099, 1989.
37. Kuhnel R., Rao B.R., Poels L.G., et al.: Multiple parameter analyses of human ovarian cancer: Morphology, immunohistochemistry, steroid hormonereceptors and aromatase. Anticancer Res. 281-286, 1988.
38. Chadha S., Rao B.R., Slotman B.J., J Van Vroonhoven C.C., Van Der Kwast T.H.: An immunohistochemical evaluation of androgen and progesterone receptors in ovarian tumors. Human Pathol. 24: 90-95, 1993.
39. Call M.C., De Giovanni C., Nicoletti G., Grilli S., Manni P., Prodi G., Gala G., Rocchetta R., Orlandi C.: The occurrence of multiple steroid receptors in ovarian tumors. Cancer 47: 1297-1302, 1981.
40. Creasman W.T., Sasso R.A., Weed J.C., Mc Carty K.S.: Ovarian carcinoma: histologic and clinical correlation of cytoplasmic estrogen and progesterone binding. Gynecol. Oncol. 12: 319-327, 1981.
41. Ford L.C., Berek J.S., Lagasse L.A., et al.: Estrogen and progesterone receptors in ovarian neoplasms. Gynecol. Oncol. 15: 229-304, 1983.
42. Friberg I.G., Kullander S., Persijn J.P., Korsten C.B.: On receptors for estrogens (E2) and androgens (DHT) in human endometrial and ovarian tumours. Acta Gynec. Scand. 57: 261-264, 1978.
43. Hamilton T.C., Davies P., Griffiths K.: Androgen and oestrogen binding in cytosols of ovarian tumours. J. Endocr. 90: 421-431, 1981.
44. Rao B.R., Slotman B.J., Geldof A.A., et al.: Correlation between tumor histology, steroid receptor status and adenosine deaminase complexing protein immunoreactivity in ovarian cancer. Int J. Gynecol. Pathol. 9: 47-54, 1990.
45. Vihko R., Isotalo H., Kauppila A., Vierikko P.: Female sex steroid receptors in gynecological malignancies: clinical correlates. J. Ster. Biochem. 19: 827-832, 1983.
46. Lanta M.: Estradiol and progesterone receptors in normal ovary and ovarian tumors. Acta. Obstet. Gynec. Scand. 63: 497-503, 1984.
47. Spona J., Gitsch E., Salzer H., Karrer K.: Estrogen and gestagen receptor in ovarian epithelial carcinoma. Obst. Gynec. 90: 229-238, 1982.
48. Van der Burg M.E.L., Henzen-Logman S.C., Foekens J.A., Berns E.M.J.J, Rodenburg C.J., Wim L.J., Klijn J.G.M.: The prognostic value of EGF receptors, determined by both immunohistochemistry and ligand binding assays, in primary epithelial ovarian cancer: a pilot study. Eur. J. Cancer. 29A (14): 1951-1957, 1993.